Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 51 cents. The company registered ...

The different types of cells in the liver can form several types of malignant (cancerous ... Most of the rest of this information is about hepatocellular carcinoma and will be referred to as liver ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

30, 2024 — Metastasis remains the primary challenge ... Scientists Discover How Excessive Red Meat Consumption Increases Colorectal Cancer Risk Oct. 23, 2024 — Scientists have uncovered ...

In patients with ERBB2-positive metastatic breast cancer (ERBB2+ MBC) and brain metastasis, more than half of deaths were due to central nervous system (CNS)–related causes; however, patients ...

James Van Der Beek, 47, Diagnosed with Colorectal Cancer: 'There’s Reason for Optimism, and I’m Feeling Good' (Exclusive) “Waking up in recovery, I remember feeling my stomach. It just felt ...

Below, we discuss colorectal cancer risk factors, its signs and things you can incorporate into your daily life to lower your risk of developing colorectal cancer and a cancer diagnosis.